{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T05:39:41Z","timestamp":1777613981016,"version":"3.51.4"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropeptides"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.npep.2021.102162","type":"journal-article","created":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T11:09:34Z","timestamp":1622027374000},"page":"102162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["A role of noradrenergic receptors in anxiolytic-like effect of high CRF in the rat frontal cortex"],"prefix":"10.1016","volume":"88","author":[{"given":"Maria","family":"\u015amia\u0142owska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Zi\u0119ba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"Domin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.npep.2021.102162_bb0005","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-0186(99)00077-7","article-title":"Localization of alpha1B-adrenergic receptor in female rat brain regions involved in stress and neuroendocrine function","volume":"35","author":"Acosta-Martinez","year":"1999","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.npep.2021.102162_bb0010","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/0006-8993(87)91642-8","article-title":"Ultrastructural localization of beta-adrenergic receptor-like immunoreactivity in the cortex and neostriatum of rat brain","volume":"29","author":"Aoki","year":"1987","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2021.102162_bb0015","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0006-8993(97)00759-2","article-title":"The CRF1 receptor mediates the excitatory actions of corticotropin releasing factor (CRF) in the developing rat brain: in vivo evidence using a novel, selective, non-peptide CRF receptor antagonist","volume":"770","author":"Baram","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2021.102162_bb0020","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1523\/JNEUROSCI.10-08-02580.1990","article-title":"Electroconvulsive shock differentially increases binding to alpha-1 adrenergic receptor subtypes in discrete regions of rat brain","volume":"10","author":"Blendy","year":"1990","journal-title":"J. Neurosci."},{"key":"10.1016\/j.npep.2021.102162_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008528","article-title":"CRF1-R activation of the dynorphin\/kappa opioid system in the mouse basolateral amygdala mediates anxiety-like behavior","volume":"4","author":"Bruchas","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.npep.2021.102162_bb0030","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0014-2999(03)01285-8","article-title":"Neuroendocrine pharmacology of stress","volume":"463","author":"Carrasco","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.npep.2021.102162_bb0035","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.neuroscience.2016.06.037","article-title":"\u03b12A adrenergic receptors highly expressed in mesoprefrontal dopamine neurons","volume":"332","author":"Castelli","year":"2016","journal-title":"Neuroscience."},{"key":"10.1016\/j.npep.2021.102162_bb0040","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0006-8993(84)90679-6","article-title":"Long-term treatment with clonidine and alpha-receptors in the brain of normotensive rats","volume":"321","author":"Cerrito","year":"1984","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2021.102162_bb0045","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/(SICI)1096-9861(20000508)420:3<305::AID-CNE3>3.0.CO;2-8","article-title":"Immunocytochemical distribution of corticotropin-releasing hormone receptor type-1 (CRF(1))-like immunoreactivity in the mouse brain: light microscopy analysis using an antibody directed against the C-terminus","volume":"420","author":"Chen","year":"2000","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.npep.2021.102162_bb0050","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0022-3565(25)13299-0","article-title":"Propranolol antagonizes the enhanced conditioned fear produced by corticotropin releasing factor","volume":"247","author":"Cole","year":"1988","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.npep.2021.102162_bb0055","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/0306-4530(95)00011-9","article-title":"Corticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders","volume":"20","author":"De Souza","year":"1995","journal-title":"Psychoneuroendocrinology."},{"key":"10.1016\/j.npep.2021.102162_bb0060","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/1874467210666170302104053","article-title":"The CRF family of neuropeptides and their receptors - mediators of the central stress response","volume":"11","author":"Dedic","year":"2018","journal-title":"Curr. Mol. Pharmacol."},{"key":"10.1016\/j.npep.2021.102162_bb0065","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1046\/j.1471-4159.2003.02239.x","article-title":"Alpha2-adrenoceptor mediated co-release of dopamine and noradrenaline from noradrenergic neurons in the cerebral cortex","volume":"884","author":"Devoto","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.npep.2021.102162_bb0070","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s12640-013-9455-7","article-title":"Group III mGlu receptor agonist, ACPT-I, exerts potential neuroprotective effects in vitro and in vivo","volume":"26","author":"Domin","year":"2014","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.npep.2021.102162_bb0075","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.bbr.2010.03.014","article-title":"Impairment of contextual conditioned fear extinction after microinjection of alpha-1-adrenergic blocker prazosin into the medial prefrontal cortex","volume":"211","author":"Do-Monte","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.npep.2021.102162_bb0080","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0165-0173(90)90012-D","article-title":"Physiological and behavioural responses to corticotrophin releasing factor administration: is CRF a mediator of anxiety or stress responses?","volume":"15","author":"Dunn","year":"1990","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.npep.2021.102162_bb0085","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ejphar.2007.11.069","article-title":"The role of corticotropin-releasing factor and noradrenaline in stress-related responses, and the inter-relationships between the two systems","volume":"583","author":"Dunn","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.npep.2021.102162_bb0090","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.nlm.2008.06.012","article-title":"Intra-amygdala anxiogenic drug infusion prior to retrieval biases rats towards the use of habit memory","volume":"90","author":"Elliott","year":"2008","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.npep.2021.102162_bb0095","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/0006-8993(93)91722-5","article-title":"Corticotropin-releasing factor enhances noradrenaline release in the rat hypothalamus assessed by intracerebral microdialysis","volume":"601","author":"Emoto","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2021.102162_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0091-3057(93)90078-8","article-title":"Beta-adrenergic receptors are involved in stress-related behavioral changes","volume":"45","author":"Gorman","year":"1993","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.npep.2021.102162_bb0105","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2174\/187152706777950684","article-title":"Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets","volume":"5","author":"Hauger","year":"2006","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.npep.2021.102162_bb0110","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0167-0115(87)90280-1","article-title":"Effects of adrenergic blockers on corticotropin-releasing factor-induced behavioral changes in rats","volume":"19","author":"Imaki","year":"1987","journal-title":"Regul. Pept."},{"key":"10.1016\/j.npep.2021.102162_bb0115","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.neuropharm.2006.06.011","article-title":"Neuropeptide Y and corticotropin-releasing factor bi-directionally modulate inhibitory synaptic transmission in the bed nucleus of the stria terminalis","volume":"51","author":"Kash","year":"2006","journal-title":"Neuropharmacology."},{"key":"10.1016\/j.npep.2021.102162_bb0120","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/cne.20271","article-title":"Imunohistochemical visualization of corticotropin-releasing factor type 1 (CRF1) receptors in monkey brain","volume":"478","author":"Kostich","year":"2004","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.npep.2021.102162_bb0125","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/cne.902900412","article-title":"Corticotropin-releasing factor immunoreactivity in monkey neocortex: an immunohistochemical analysis","volume":"290","author":"Lewis","year":"1989","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.npep.2021.102162_bb0130","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1073\/pnas.92.3.836","article-title":"Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain","volume":"92","author":"Lovenberg","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.npep.2021.102162_bb0135","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ygcen.2005.12.006","article-title":"Regulation of behavioral responses by corticotropin-releasing factor","volume":"146","author":"Lowry","year":"2006","journal-title":"Gen. Comp. Endocrinol."},{"key":"10.1016\/j.npep.2021.102162_bb0140","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1177\/1073858412464527","article-title":"Medial prefrontal cortex: multiple roles in fear and extinction","volume":"19","author":"Maroun","year":"2013","journal-title":"Neuroscientist."},{"key":"10.1016\/j.npep.2021.102162_bb0145","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1007\/s00213-014-3535-0","article-title":"Beta-2 adrenergic receptors mediate stress-evoked reinstatement of cocaine-induced conditioned place preference and increases in CRF mRNA in the bed nucleus of the stria terminalis in mice","volume":"231","author":"McReynolds","year":"2014","journal-title":"Psychopharmacology"},{"issue":"Suppl. 1","key":"10.1016\/j.npep.2021.102162_bb0150","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0196-9781(84)90265-1","article-title":"Corticotropin releasing factor (CRF)-like immunoreactivity in the rat central nervous system. Extrahypothalamic distribution","volume":"5","author":"Merchenthaler","year":"1984","journal-title":"Peptides."},{"key":"10.1016\/j.npep.2021.102162_bb0155","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.biopsych.2010.12.030","article-title":"\u03b2-Adrenergic receptors enhance excitatory transmission in the bed nucleus of the stria terminalis through a corticotrophin-releasing factor receptor-dependent and cocaine-regulated mechanism","volume":"69","author":"Nobis","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.npep.2021.102162_bb0160","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1272\/jnms.78.286","article-title":"Microinjection of different doses of corticotropin-releasing factor into the medial prefrontal cortex produces effects opposing anxiety-related behavior in rats","volume":"78","author":"Ohata","year":"2011","journal-title":"J. Nippon Med. Sch."},{"key":"10.1016\/j.npep.2021.102162_bb0165","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.euroneuro.2010.07.008","article-title":"In vivo potentiation of reboxetine and citalopram effect on extracellular noradrenaline in rat brain by \u03b12-adrenoceptor antagonism","volume":"20","author":"Ortega","year":"2010","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.npep.2021.102162_bb0170","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.neuroscience.2009.07.054","article-title":"Peripheral anxiogenic drug injections differentially affect cognitive and habit memory: role of basolateral amygdala","volume":"164","author":"Packard","year":"2009","journal-title":"Neuroscience."},{"key":"10.1016\/j.npep.2021.102162_bb0175","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0361-9230(99)00241-5","article-title":"Hippocampal norepinephrine-like voltametric responses to infusion of corticotrophin releasing factor into locus coeruleus","volume":"51","author":"Palamarchouk","year":"2000","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.npep.2021.102162_bb0180","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0006-8993(02)02983-9","article-title":"Hippocampal noradrenergic responses to CRF injected into the locus coeruleus of unanesthetized rats","volume":"950","author":"Palamarchouk","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2021.102162_bb0185","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.neulet.2009.04.023","article-title":"beta1-Adrenoceptor distribution in the rat brain: an immunohistochemical study","volume":"458","author":"Paschalis","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.npep.2021.102162_bb0190","series-title":"The Rat Nervous System","author":"Paxinos","year":"1995"},{"key":"10.1016\/j.npep.2021.102162_bb0195","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.npep.2021.102162_bb0200","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1523\/JNEUROSCI.14-07-04252.1994","article-title":"Distribution of alpha 1 adrenoceptors in rat brain revealed by in situ hybridization experiments utilizing subtype-specific probes","volume":"14","author":"Pieribone","year":"1994","journal-title":"J. Neurosci."},{"key":"10.1016\/j.npep.2021.102162_bb0205","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S0022-3565(25)22637-4","article-title":"Clonidine enhances the release of endogenous gamma-aminobutyric acid through alpha-2 and alpha-1 presynaptic adrenoceptors differentially located in rat cerebral cortex subregions","volume":"245","author":"Pittaluga","year":"1988","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.npep.2021.102162_bb0210","doi-asserted-by":"crossref","first-page":"31","DOI":"10.31887\/DCNS.2002.4.1\/jreul","article-title":"On the role of corticotropin-releasing hormone receptors in anxiety and depression","volume":"4","author":"Reul","year":"2002","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.npep.2021.102162_bb0215","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1021\/jm0613875","article-title":"Stressin1-a, a potent corticotropin releasing factor receptor 1 (CRF1)-selective peptide agonist","volume":"50","author":"Rivier","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.npep.2021.102162_bb0220","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/(SICI)1096-9861(19960812)372:1<135::AID-CNE9>3.0.CO;2-4","article-title":"Distribution of alpha 2C-adrenergic receptor-like immunoreactivity in the rat central nervous system","volume":"372","author":"Rosin","year":"1996","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.npep.2021.102162_bb0225","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1159\/000127071","article-title":"Activation of noradrenergic neurons in the locus coeruleus by corticotropin-releasing factor. A microdialysis study","volume":"63","author":"Schulz","year":"1996","journal-title":"Neuroendocrinology."},{"key":"10.1016\/j.npep.2021.102162_bb0230","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0361-9230(94)00166-X","article-title":"Corticotropin releasing factor administered into the locus coeruleus, but not the parabrachial nucleus, stimulates norepinephrine release in the prefrontal cortex","volume":"36","author":"Smagin","year":"1995","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.npep.2021.102162_bb0235","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0143-4179(94)90074-4","article-title":"The role of alpha-1 adrenergic receptors in the stimulating effect of neuropeptide Y (NPY) on rat behavioural activity","volume":"26","author":"Smia\u0142owska","year":"1994","journal-title":"Neuropeptides."},{"key":"10.1016\/j.npep.2021.102162_bb0240","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0143-4179(92)90038-X","article-title":"The behavioural effects of neuropeptide Y (NPY) injection into the rat brain frontal cortex","volume":"21","author":"Smia\u0142owski","year":"1992","journal-title":"Neuropeptides."},{"key":"10.1016\/j.npep.2021.102162_bb0245","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0091-3057(88)90482-0","article-title":"Biphasic effects of clonidine on conflict behavior: involvement of different alpha-adrenoceptors","volume":"30","author":"S\u00f6derpalm","year":"1988","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.npep.2021.102162_bb0250","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0163-7258(95)02010-1","article-title":"Central noradrenergic neurones and stress","volume":"68","author":"Stanford","year":"1995","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.npep.2021.102162_bb0255","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1046\/j.1471-4159.2001.00484.x","article-title":"Presynaptic autoreceptors in the third decade: focus on alpha2-adrenoceptors","volume":"78","author":"Starke","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.npep.2021.102162_bb0260","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S0006-3223(99)00170-5","article-title":"Corticotropin-releasing hormone receptor subtypes and emotion","volume":"46","author":"Steckler","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.npep.2021.102162_bb0265","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.neuint.2008.01.002","article-title":"Effects of chlordiazepoxide on footshock- and corticotrophin releasing factor- induced inreases in cortical and hypothalamic norepinephrine secretion in rats","volume":"52","author":"Swiergiel","year":"2008","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.npep.2021.102162_bb0270","doi-asserted-by":"crossref","first-page":"17416","DOI":"10.1523\/JNEUROSCI.3087-11.2011","article-title":"An anxiolytic role for CRF receptor type 1 in the globus pallidus","volume":"31","author":"Sztainberg","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.npep.2021.102162_bb0275","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0149-7634(01)00046-X","article-title":"Role of CRF(1) and CRF(2) receptors in fear and anxiety","volume":"25","author":"Takahashi","year":"2001","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.npep.2021.102162_bb0280","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.pnpbp.2012.05.017","article-title":"The effects of the co-administration of the \u03b1\u2081-adrenoreceptor antagonist prazosin on the anxiolytic effect of citalopram in conditioned fear stress in the rat","volume":"39","author":"Takamura","year":"2012","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.npep.2021.102162_bb0285","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/(SICI)1096-9861(19960812)372:1<111::AID-CNE8>3.0.CO;2-6","article-title":"Distribution of alpha 2A-adrenergic receptor-like immunoreactivity in the rat central nervous system","volume":"372","author":"Talley","year":"1996","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.npep.2021.102162_bb0290","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2486\/indhealth.37.143","article-title":"Emotional stress and characteristics of brain noradrenaline release in the rat","volume":"37","author":"Tanaka","year":"1999","journal-title":"Ind. Health"},{"key":"10.1016\/j.npep.2021.102162_bb0295","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.pbb.2004.09.020","article-title":"Allostasis and dysregulation of corticotropin-releasing factor and neuropeptide Y systems: implications for the development of alcoholism","volume":"79","author":"Valdez","year":"2004","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.npep.2021.102162_bb0300","first-page":"245","article-title":"Chemical and biological characterization of corticotropin releasing factor","volume":"39","author":"Vale","year":"1983","journal-title":"Recent Prog. Horm. Res."},{"key":"10.1016\/j.npep.2021.102162_bb0305","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/1096-9861(20001211)428:2<191::AID-CNE1>3.0.CO;2-U","article-title":"Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse","volume":"428","author":"Van Pett","year":"2000","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.npep.2021.102162_bb0310","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0006-8993(89)90674-4","article-title":"Immunocytochemical localization of beta-adrenergic receptors in the rat brain","volume":"485","author":"Wanaka","year":"1989","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2021.102162_bb0315","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1124\/jpet.107.123208","article-title":"Subtype-selective corticotropin-releasing factor receptor agonists exert contrasting, but not opposite, effects on anxiety-related behavior in rats","volume":"323","author":"Zhao","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.npep.2021.102162_bb0320","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.npep.2008.05.004","article-title":"The behavioural and electrophysiological effects of CRF in rat frontal cortex","volume":"42","author":"Zieba","year":"2008","journal-title":"Neuropeptides."}],"container-title":["Neuropeptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417921000482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417921000482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T20:37:24Z","timestamp":1758919044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143417921000482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":64,"alternative-id":["S0143417921000482"],"URL":"https:\/\/doi.org\/10.1016\/j.npep.2021.102162","relation":{},"ISSN":["0143-4179"],"issn-type":[{"value":"0143-4179","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A role of noradrenergic receptors in anxiolytic-like effect of high CRF in the rat frontal cortex","name":"articletitle","label":"Article Title"},{"value":"Neuropeptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.npep.2021.102162","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102162"}}